ArticleThe international journal of neuropsychopharmacology2022

Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System.

Michele Fusaroli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.